Merkhofer and colleagues, in an attempt to elucidate the pathway leading to NF-κB activation, proved that ERBB2 requires IKKα to activate NF-κB through the canonical pathway independently of the PI3K pathway in ERBB2-positive breast cancer cells [21]. The gene discussed is NFKB1; the disease is breast carcinoma.